Cargando…

Decision Tree for Early Detection of Cognitive Impairment by Community Pharmacists

Purpose: The early detection of Mild Cognitive Impairment (MCI) is essential in aging societies where dementia is becoming a common manifestation among the elderly. Thus our aim is to develop a decision tree to discriminate individuals at risk of MCI among non-institutionalized elderly users of comm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Climent, Maria Teresa, Pardo, Juan, Muñoz-Almaraz, Francisco Javier, Guerrero, Maria Dolores, Moreno, Lucrecia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215965/ https://www.ncbi.nlm.nih.gov/pubmed/30420808 http://dx.doi.org/10.3389/fphar.2018.01232

Ejemplares similares

Importance of Increasing Modifiable Risk Factors Knowledge on Alzheimer’s Disease Among Community Pharmacists and General Practitioners in Spain
por: Alacreu, Mónica, et al.
Publicado: (2019)

Pharmacist-Physician Interprofessional Collaboration to Promote Early Detection of Cognitive Impairment: Increasing Diagnosis Rate
por: Ramos, Hernán, et al.
Publicado: (2021)

Lifestyle Variables Such as Daily Internet Use, as Promising Protective Factors against Cognitive Impairment in Patients with Subjective Memory Complaints. Preliminary Results
por: Ramos, Hernán, et al.
Publicado: (2021)

The effect of an anti-inflammatory diet on chronic pain: a pilot study
por: Sala-Climent, Marta, et al.
Publicado: (2023)

Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
por: Vidal, Verónica, et al.
Publicado: (2021)

A Targeted Approach to Improve Asthma Control Using Community Pharmacists
por: Serhal, Sarah, et al.
Publicado: (2021)

Effectiveness of Community Pharmacy Diabetes and Hypertension Care Program: An Unexplored Opportunity for Community Pharmacists in Pakistan
por: Malik, Madeeha, et al.
Publicado: (2022)

Attitudes, Practices, and Barriers of Malaysian Community Pharmacists Toward Provision of Weight Management Services
por: Verma, Rohit Kumar, et al.
Publicado: (2019)

Assessment of community pharmacists’ knowledge about drug-drug interactions in Jeddah, Saudi Arabia
por: Alorfi, Nasser M., et al.
Publicado: (2023)

Community pharmacists’ skills and practice regarding dispensing fiscalized substances: a cross-sectional survey
por: El-Dahiyat, Faris, et al.
Publicado: (2023)

Construction of a Non-Mutually Exclusive Decision Tree for Medication Recommendation of Chronic Heart Failure
por: Bai, Yongyi, et al.
Publicado: (2022)

Defining and supporting a professional role for pharmacists associated with traditional and complementary medicines: a cross-country survey of pharmacists
por: Harnett, Joanna E., et al.
Publicado: (2023)

Medication Review by Community Pharmacists for Type 2 Diabetes Patients in Routine Care: Results of the DIATHEM-Study
por: Schindler, Elisabeth, et al.
Publicado: (2020)

Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2022)

Addressing Psychosocial Factors in Cognitive Impairment Screening from a Holistic Perspective: The DeCo-Booklet Methodology Design and Pilot Study
por: García, Cristina, et al.
Publicado: (2022)

Nutraceuticals in cognitive impairment and Alzheimer’s disease
por: Mecocci, P., et al.
Publicado: (2014)

Patient Satisfaction and Their Willingness to Pay for a Pharmacist Counseling Session in Hospital and Community Pharmacies in Saudi Healthcare Settings
por: AlShayban, Dhfer Mahdi, et al.
Publicado: (2020)

A National Survey of Community Pharmacists’ Viewpoints About Pharmacovigilance and Adverse Drug Reaction Reporting in Saudi Arabia
por: Alsheikh, Mona Y., et al.
Publicado: (2022)

Emergency supply of prescription-only medicines to patients by community pharmacists: a mixed methods evaluation incorporating patient, pharmacist and GP perspectives
por: Morecroft, Charles W, et al.
Publicado: (2015)

Influence of Lifestyles on Mild Cognitive Impairment: A Decision Tree Model Study
por: Wang, Zongqiu, et al.
Publicado: (2020)

Community pharmacists’ perceived value on precision medicine, desired training components, and exposure during pharmacy education: Malaysia’s experience
por: Naimat, Faiza, et al.
Publicado: (2022)

Community pharmacists’ views and experiences toward over-the-counter medicines misuse and abuse in Saudi Arabia: A qualitative study
por: Algarni, Mohammad, et al.
Publicado: (2022)

Community pharmacists’ perspectives on cardiovascular disease pharmaceutical care in the United Arab Emirates: a questionnaire survey-based analysis
por: Jairoun, Ammar Abdulrahman, et al.
Publicado: (2023)

Polypharmacy Cut-Off for Gait and Cognitive Impairments
por: Langeard, Antoine, et al.
Publicado: (2016)

Allergic Asthma-Induced Cognitive Impairment is Alleviated by Dexamethasone
por: Ren, Mengli, et al.
Publicado: (2021)

Editorial: Cognitive Impairment: Therapy Momentum in the Continuum of Life
por: Nifli, Artemissia-Phoebe, et al.
Publicado: (2021)

Transitioning Pharmacogenomics into the Clinical Setting: Training Future Pharmacists
por: Frick, Amber, et al.
Publicado: (2016)

Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats
por: Peres, Fernanda F., et al.
Publicado: (2016)

Pharmacists’ Knowledge of Factors Associated with Dementia: The A-to-Z Dementia Knowledge List
por: Ramos, Hernán, et al.
Publicado: (2021)

Practice Guidelines for Clinical Pharmacists in Middle to Low Income Countries
por: Bronkhorst, Elmien, et al.
Publicado: (2020)

Pharmacists’ experiences on adverse drug reaction: 10 years later
por: Karuppannan, Mahmathi, et al.
Publicado: (2022)

Acceptance rate of clinical pharmacists’ recommendations—an ongoing journey for integration
por: Peled, Orit, et al.
Publicado: (2023)

Pharmacotherapy of mild cognitive impairment
por: Gauthier, Serge
Publicado: (2004)

Evaluation of the Long-Term Impact on Quality After the End of Pharmacist-Driven Warfarin Therapy Management in Patients With Poor Quality of Anticoagulation Therapy
por: Marcatto, Leiliane Rodrigues, et al.
Publicado: (2020)

The A-to-Z factors associated with cognitive impairment. Results of the DeCo study
por: Gil-Peinado, María, et al.
Publicado: (2023)

Osthole Ameliorates Estrogen Deficiency-Induced Cognitive Impairment in Female Mice
por: Adu-Nti, Frank, et al.
Publicado: (2021)

Gut Microbial Dysbiosis and Cognitive Impairment in Bipolar Disorder: Current Evidence
por: Dai, Wenyu, et al.
Publicado: (2022)

Effect of Tanshinone IIA on Gut Microbiome in Diabetes-Induced Cognitive Impairment
por: Zheng, Yanfang, et al.
Publicado: (2022)

The efficacy and safety of post-stroke cognitive impairment therapies: an umbrella review
por: Li, Yongbiao, et al.
Publicado: (2023)

Factors influencing clinical pharmacists’ integration into the clinical multidisciplinary care team
por: Wang, Chenyu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_okntdl8gp9ha02biejepj4j7k4